TBILA

Across TCGA pan-cancer cohorts, TBILA RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated TBILA data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher TBILA RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TBILA expression acts as an unfavorable survival marker, although some lineages such as BRCA and READ show a favorable association.

LIHC, LGG, and THCA are the cancer types where TBILA RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Quartile	All	0.570	0.751	<.001	42	view →
LGG	OS	Median	All	0.754	0.863	<.001	39	view →
THCA	OS	Median	All	0.980	0.998	.002	38	view →
PRAD	DFS	Tertile	All	0.694	0.907	.001	28	view →
SARC	DFS	Quartile	All	0.184	0.471	<.001	23	view →
BRCA	OS	Median	IV	0.742	0.358	.015	21	view →
ESCA	OS	Median	II,III,IV	0.375	0.604	.010	18	view →
READ	OS	Median	III,IV	1.000	0.818	.010	18	view →
KIRP	OS	Tertile	III,IV	0.109	0.745	.004	18	view →
THYM	OS	Median	II,III,IV	0.960	0.611	<.001	17	view →
ACC	DFS	Median	III,IV	0.816	0.297	.006	13	view →
CESC	DFS	Tertile	III,IV	0.213	0.703	.031	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

TBILA–LIHC (OS)

Open the LIHC breakdown →